Macter International (KAR:MACTER) Net Current Asset Value: ₨0.00 (As of . 20)


KAR:MACTER Macter International Ltd KAR:MACTER
11 GF Score
Price ₨294.83
! 1 Warning Sign
View Full Analysis

What is Macter International Net Current Asset Value?

Macter International KAR:MACTER -4.46% 11 Net Current Asset Value is ₨0.00 as of . 20. GuruFocus rates KAR:MACTER with a GF Score™ of 11/100. The stock has 1 warning sign investors should review. Among 609 Drug Manufacturers companies, Macter International ranks worse than 164203.45% on this metric.

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

Macter International's net current asset value per share for the quarter that ended in . 20 was ₨0.00.

The historical rank and industry rank for Macter International's Net Current Asset Value or its related term are showing as below:

KAR:MACTER's Price-to-Net-Current-Asset-Value is not ranked *
in the Drug Manufacturers industry.
Industry Median: 5.63
* Ranked among companies with meaningful Price-to-Net-Current-Asset-Value only.

Macter International  (KAR:MACTER) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


Macter International Net Current Asset Value Related Terms


Macter International Net Current Asset Value Historical Data

* Premium members only.

The historical data trend for Macter International's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Macter International Net Current Asset Value Chart

Macter International Annual Data
Trend
Net Current Asset Value

Macter International Semi-Annual Data
Net Current Asset Value

KAR:MACTER vs ZTS, UTHR, VTRS: Net Current Asset Value Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Macter International's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Macter International Price-to-Net-Current-Asset-Value vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Macter International's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where Macter International's Price-to-Net-Current-Asset-Value falls into.


KAR:MACTER
11GF Score
Macter International Ltd KAR:MACTER
Net Current Asset Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Macter International Net Current Asset Value Calculation

Macter International's Net Current Asset Value (NCAV) per share for the fiscal year that ended in . 20 is calculated as

Net Current Asset Value Per Share(A: . 20 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(-N/A--)/0
=N/A

Macter International's Net Current Asset Value (NCAV) per share for the quarter that ended in . 20 is calculated as

Net Current Asset Value Per Share(Q: . 20 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(-N/A--)/0
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Net Current Asset Value of ₨0.00 mean?
Macter International (KAR:MACTER) has a Net Current Asset Value of ₨0.00 as of . 20. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Macter International and its competitors. According to the industry distribution chart, Macter International ranks #999999 out of 609 companies in the Drug Manufacturers industry.
Is Macter International's Net Current Asset Value too high?
Macter International's current Net Current Asset Value is ₨0.00. Based on the distribution chart, Macter International ranks #999999 out of 609 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Macter International has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Macter International's Net Current Asset Value compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Macter International ranks #999999 out of 609 companies for Net Current Asset Value. This places Macter International in the lower half of its industry. The industry median Net Current Asset Value is 5.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Current Asset Value for a Drug Manufacturers company?
The median Net Current Asset Value among Drug Manufacturers companies is 5.63, based on 609 companies in the industry. Companies in the top quartile (top 25%) have a Net Current Asset Value significantly above this median, while those in the bottom quartile fall well below. However, Net Current Asset Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Current Asset Value mean?
A high Net Current Asset Value can signal that a stock is expensive relative to its fundamentals. Ben Graham's net current asset value equals the per-share value of total current assets less total liabilities. View historical data on Macter International and its competitors. For the Drug Manufacturers industry, the median Net Current Asset Value is 5.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Macter International's current Net Current Asset Value is ₨0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Macter International stock overvalued right now?
Macter International (KAR:MACTER) has a current Net Current Asset Value of ₨0.00. The current Net Current Asset Value is ₨0.00. Macter International's overall GF Score™ is 11/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Current Asset Value calculated?
Net Current Asset Value is calculated from a company's financial statements. For Macter International (KAR:MACTER), the current Net Current Asset Value is ₨0.00 as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Macter International Business Description

Address F-216, SITE, Karachi, SD, PAK, 75700
Macter International Ltd is engaged in the manufacturing and marketing of pharmaceutical products and formulations for healthcare companies in Pakistan. It is covering almost all therapeutic categories including Antibiotics, Anti-allergy, cardiovascular, Anti-viral, and many more.
11GF Score

Get the complete analysis for KAR:MACTER

Net Current Asset Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨294.83
Price